This is glowing article about the father of LSD. Albert is honored as a tolerant man who was thoughtful in his pursuits of science and spirituality.

This is well written article that explores stories of two patients in Dr. Mithoefers study, the history of MDMA, and efforts of MAPS and other scientists in the psychedelic research renaissance.

This comprehensive review of LSD was authored by colleagues of MAPS. MAPS’ Swiss LSD/end-of-life anxiety study is the research that Dr. Passie referred to at the end of the following abstract:

“With the entry of new methods of research and better study oversight, scientific interest in LSD has resumed for brain research and experimental treatments. Due to the lack of any comprehensive review since the 1950s and the widely dispersed experimental literature, the present review focuses on all aspects of the pharmacology and psychopharmacology of LSD. A thorough search of the experimental literature regarding the pharmacology of LSD was performed and the extracted results are given in this review. (Psycho-) pharmacological research on LSD was extensive and produced nearly 10,000 scientific papers. The pharmacology of LSD is complex and its mechanisms of action are still not completely understood. LSD is physiologically well tolerated and psychological reactions can be controlled in a medically supervised setting, but complications may easily result from uncontrolled use by layman. Actually there is new interest in LSD as an experimental tool for elucidating neural mechanisms of (states of) consciousness and there are recently discovered treatment options with LSD in cluster headache and with the terminally ill.”

The renowned publication Nature mentioned the preliminary successes of our MDMA/PTSD pilot study.